I have seen a number of popular news articles late
Post# of 148155
It appears that ALS is tightly linked to elevated RANTES. Much mud has been slung at Cytodyn for its simultaneous exploration of multiple indications, but this would seem an appealing and very easy target to address.
I have known many wonderful people taken far to early by Cancer, HIV and Alzheimer's, both early and late onset. The tragedy of ALS, with its seemingly inexplicable appearance in the prime of life, ranks at the top of my list of heartbreaks.
I know we small and not so small shareholders likely don't get to choose the target of the next clinical trial. I guess I'll put it on my Christmas list and send it in December.
I can believe in miracles. Leronlimab has arrived.